Alert detail

LCD L37356: MolDX: EndoPredict Breast Cancer Gene Expression Test — CGS

Policy ID: LCD-L37356Specialty: OncologyAdded: 6/5/2026Effective: 2026-04-16lcd
High

What changed

New coverage for EndoPredict test effective 04/16/2026.

Who’s affected: Oncology billing teams · Effective: 2026-04-16

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 6 billing codes.

Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.

Not ready to subscribe?

Get the free weekly reimbursement brief for Oncology— the week’s changes and deadlines, delivered to your inbox. No account required.